News

Kessler Topaz Meltzer & Check, LLP Reminds Investors of BioXcel Therapeutics, Inc. of Deadline in Securities Fraud Class Action Lawsuit

by

RADNOR, Pa., Aug. 8, 2023 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of Connecticut against BioXcel Therapeutics, Inc. (“BioXcel”) (NASDAQ: BTAI). The action charges BioXcel with violations of the federal securities … Read more

Repurchases of shares by Concentric AB during week 31, 2023

by

REDDITCH, England, Aug. 8, 2023 /PRNewswire/ — Between 31 July 2023 and 4 August 2023 Concentric AB (LEI code 5493002G9GMTKIP3PW19) (“Concentric”) has repurchased in total 14,769 own shares (ISIN: SE0003950864) as part of the repurchase program initiated by the Board. The repurchases form part of the repurchase program of a maximum of 3,519,172 own shares … Read more

Envista Holdings Corporation Announces Proposed Convertible Senior Notes Offering

by

BREA, Calif., Aug. 7, 2023 /PRNewswire/ — Envista Holdings Corporation (NYSE: NVST) (“Envista”) today announced its intention to offer, subject to market and other conditions, $435,000,000 in aggregate principal amount of Convertible Senior Notes due 2028 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of … Read more

Piramal Pharma Limited annonce ses résultats consolidés pour le premier trimestre de l’exercice 2024

by

MUMBAI, Inde, 6 août 2023 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a annoncé aujourd’hui ses résultats consolidés pour le premier trimestre (T1) clos le 30 juin 2023. Nandini Piramal, Chairperson, Piramal Pharma Limited Faits saillants des résultats financiers consolidés : (En crores INR) Détails T1 Exercice 2024 T1 Exercice 2023 Croissance annuelle T4 Exercice 2023 Croissance trimestrielle … Read more

World’s Most Successful Athletic Fundraiser Pan-Mass Challenge Brings Together Thousands of Cyclists to Raise $70 Million for Cancer Research

by

The PMC Aims to Exceed $970 Million Raised for Dana-Farber Cancer Institute with Most Ambitious Fundraising Goal to Date  BOSTON, Aug. 5, 2023 /PRNewswire/ — On Saturday, August 5 and Sunday, August 6, the Pan-Mass Challenge (PMC), the world’s single most successful athletic fundraiser, will bring together 6,500 riders and over 3,000 volunteers for its 44th ride. … Read more

Global Connected Healthcare Market Report 2023-2027 & 2032

by

DUBLIN, Aug. 4, 2023 /PRNewswire/ — The “Connected Healthcare Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. The global connected healthcare market grew from $100.03 billion in 2022 to $127.53 billion in 2023 at a compound annual growth rate (CAGR) of 27.5%. The connected healthcare market is expected to grow to $345.49 billion … Read more

ACCORD et HIPRA concluent un accord de distribution exclusif pour commercialiser le vaccin COVID-19 (BIMERVAX®) de HIPRA au Royaume-Uni

by

BIMERVAX® : une dose de rappel d’un vaccin bivalent à base de protéines recombinantes permet d’immuniser les personnes âgées de plus de 16 ans LONDRES et GERONE, Espagne, 4 août 2023 /PRNewswire/ — Accord Healthcare, Ltd. (Accord) et HIPRA ont annoncé aujourd’hui qu’ils ont conclu un accord de distribution exclusif pour commercialiser le vaccin COVID-19 de HIPRA … Read more

Aardvark Therapeutics Announces Receipt of FDA Rare Pediatric Disease Designation for Prader-Willi Syndrome and Expands the Ongoing Phase 2 Clinical Trial

by

The FDA granted Aardvark Therapeutics a Rare Pediatric Designation for the use of ARD-101 in Prader-Willi Syndrome (PWS), a rare genetic disease characterized by extreme and unabating hunger. Aardvark’s Phase 2 trial of oral ARD-101 in young adults with PWS is now open for enrollment of additional subjects. SAN DIEGO, Aug. 3, 2023 /PRNewswire/ — Aardvark Therapeutics, … Read more

Adoption of Eco-Friendly Decontamination Products Gaining Momentum

by

DUBLIN, Aug. 2, 2023 /PRNewswire/ — The “Bio Decontamination Market by Product (Equipment, Consumables), Agent (Hydrogen Peroxide, Chlorine Dioxide, Nitrogen Dioxide), Type (Room Decontamination, Chamber Decontamination), End user (Hospital & Healthcare facilities) – Global Forecast to 2028” report has been added to  ResearchAndMarkets.com’s offering. The global bio decontamination market is projected to reach USD 339 million … Read more